How many mosquito nets are needed to maintain universal coverage: an update.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 19 01 2023
accepted: 26 05 2023
medline: 3 7 2023
pubmed: 1 7 2023
entrez: 30 6 2023
Statut: epublish

Résumé

Insecticide-treated nets (ITNs) have served as the cornerstone of malaria vector control in sub-Saharan Africa for the past two decades. Over 2.5 billion ITNs have been delivered since 2004 primarily through periodic mass distribution campaigns scheduled at approximately three-year intervals, aligning with the expected lifespan of nets. Recent work indicates that ITN retention times are less than two years in most countries, raising key questions for quantification approaches and delivery frequency for ITN distribution. This paper models several quantification approaches for five typical ITN distribution strategies, estimates the proportion of the population with access to an ITN, and presents recommended quantification approaches to meet global targets for ITN access and use. A stock and flow model with annual timesteps was used to model ITN distribution and resulting ITN access for 2020-2035 under five scenarios in 40 countries: (1) three-year mass campaigns, (2) full-scale annual continuous distribution, (3) three-year mass campaigns plus continuous distribution in the years between campaigns, (4) three-year mass campaigns at different quantification approaches, (5) two-year mass campaigns at different quantification approaches. All scenarios included ITN distribution to pregnant women at antenatal clinics and infants at immunization visits. The current status quo of conducting mass campaigns every three years using a population/1.8 quantifier is insufficient to achieve or maintain targets of 80% population access to ITNs in most malaria-endemic countries, given most estimated retention times are less than three years. Tailored three- or two-year mass campaigns were less efficient than annual continuous distribution strategies in nearly all settings. For countries with at least 2.5 year median ITN retention times, full scale continuous distribution provided better ITN access while needing 20-23% fewer ITNs compared to current mass campaigns. Given variation in ITN retention times across countries, tailored quantification approaches for mass campaigns and continuous distribution strategies are warranted. Continuous distribution strategies are likely to offer more efficient ways to maintain ITN coverage, with fewer nets, where ITN retention times are at least two and a half years. National malaria programmes and their funding partners should work to increase the number of ITNs available to those vulnerable to malaria, while at the same time working to extend the useful life of these critical commodities.

Sections du résumé

BACKGROUND BACKGROUND
Insecticide-treated nets (ITNs) have served as the cornerstone of malaria vector control in sub-Saharan Africa for the past two decades. Over 2.5 billion ITNs have been delivered since 2004 primarily through periodic mass distribution campaigns scheduled at approximately three-year intervals, aligning with the expected lifespan of nets. Recent work indicates that ITN retention times are less than two years in most countries, raising key questions for quantification approaches and delivery frequency for ITN distribution. This paper models several quantification approaches for five typical ITN distribution strategies, estimates the proportion of the population with access to an ITN, and presents recommended quantification approaches to meet global targets for ITN access and use.
METHODS METHODS
A stock and flow model with annual timesteps was used to model ITN distribution and resulting ITN access for 2020-2035 under five scenarios in 40 countries: (1) three-year mass campaigns, (2) full-scale annual continuous distribution, (3) three-year mass campaigns plus continuous distribution in the years between campaigns, (4) three-year mass campaigns at different quantification approaches, (5) two-year mass campaigns at different quantification approaches. All scenarios included ITN distribution to pregnant women at antenatal clinics and infants at immunization visits.
RESULTS RESULTS
The current status quo of conducting mass campaigns every three years using a population/1.8 quantifier is insufficient to achieve or maintain targets of 80% population access to ITNs in most malaria-endemic countries, given most estimated retention times are less than three years. Tailored three- or two-year mass campaigns were less efficient than annual continuous distribution strategies in nearly all settings. For countries with at least 2.5 year median ITN retention times, full scale continuous distribution provided better ITN access while needing 20-23% fewer ITNs compared to current mass campaigns.
CONCLUSION CONCLUSIONS
Given variation in ITN retention times across countries, tailored quantification approaches for mass campaigns and continuous distribution strategies are warranted. Continuous distribution strategies are likely to offer more efficient ways to maintain ITN coverage, with fewer nets, where ITN retention times are at least two and a half years. National malaria programmes and their funding partners should work to increase the number of ITNs available to those vulnerable to malaria, while at the same time working to extend the useful life of these critical commodities.

Identifiants

pubmed: 37391703
doi: 10.1186/s12936-023-04609-z
pii: 10.1186/s12936-023-04609-z
pmc: PMC10314435
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

200

Subventions

Organisme : Bill & Melinda Gates Foundation
ID : INV-016322
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Front Public Health. 2016 Aug 15;4:153
pubmed: 27574601
EClinicalMedicine. 2018 Jul;1:62-69
pubmed: 30294720
Malar J. 2021 Jan 19;20(1):45
pubmed: 33468114
PLoS Med. 2010 Jan 26;7(1):e1000221
pubmed: 20126256
PLoS One. 2014 May 21;9(5):e97496
pubmed: 24848768
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):40-48
pubmed: 36228915
BMJ Glob Health. 2021 May;6(5):
pubmed: 33947708
Malar J. 2015 Mar 24;14:123
pubmed: 25890233
Nat Commun. 2021 Jun 11;12(1):3589
pubmed: 34117240
Malar J. 2013 May 04;12:150
pubmed: 23641705
PLoS Med. 2020 Sep 18;17(9):e1003248
pubmed: 32946451
Malar J. 2018 Apr 3;17(1):147
pubmed: 29615044
Malar J. 2023 Feb 21;22(1):61
pubmed: 36810015
PLoS One. 2017 Jul 5;12(7):e0179528
pubmed: 28678846
Malar J. 2020 May 24;19(1):187
pubmed: 32448313
Health Policy Plan. 2022 Feb 8;37(2):243-254
pubmed: 34918055
Malar J. 2020 Mar 30;19(1):124
pubmed: 32228592
Elife. 2015 Dec 29;4:
pubmed: 26714109
Malar J. 2022 Aug 26;21(1):246
pubmed: 36028866
Parasit Vectors. 2017 Nov 13;10(1):564
pubmed: 29132421
Malar J. 2020 May 24;19(1):189
pubmed: 32448213
Malar J. 2010 Nov 18;9:330
pubmed: 21087460
Malar J. 2018 Nov 14;17(1):423
pubmed: 30428916
Malar J. 2020 Apr 17;19(1):158
pubmed: 32303240
Malar J. 2021 Jan 7;20(1):26
pubmed: 33413388
Lancet Planet Health. 2022 Feb;6(2):e100-e109
pubmed: 35065707
Malar J. 2020 Jun 17;19(1):209
pubmed: 32552819

Auteurs

Hannah Koenker (H)

Tropical Health LLP, Baltimore, USA. hannah@trophealth.com.

Josh Yukich (J)

Center for Applied Malaria Research and Evaluation, Tulane University, New Orleans, USA.

Marcy Erskine (M)

International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland.

Robert Opoku (R)

International Federation of Red Cross and Red Crescent Societies, Nairobi, Kenya.

Eleanore Sternberg (E)

Tropical Health LLP, Liverpool, UK.

Albert Kilian (A)

Tropical Health LLP, Montagut, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH